Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies.

Wu K, Wang X, Xie Z, Liu Z, Lu Y.

J Int Med Res. 2013 Feb;41(1):31-7. doi: 10.1177/0300060513476988. Epub 2013 Jan 24.

PMID:
23569127
2.

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.

Okkels H, Sigsgaard T, Wolf H, Autrup H.

Cancer Epidemiol Biomarkers Prev. 1997 Apr;6(4):225-31.

3.
4.

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.

Hsieh FI, Pu YS, Chern HD, Hsu LI, Chiou HY, Chen CJ.

Br J Cancer. 1999 Oct;81(3):537-41.

5.

The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.

Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA.

Cancer Res. 1998 Aug 15;58(16):3603-10.

6.
7.

XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.

Stern MC, Johnson LR, Bell DA, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):1004-11.

9.

Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies.

Zhang R, Xu G, Chen W, Zhang W.

Mol Biol Rep. 2011 Apr;38(4):2491-7. doi: 10.1007/s11033-010-0386-6. Epub 2010 Nov 17.

PMID:
21082260
10.

Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.

Gu J, Liang D, Wang Y, Lu C, Wu X.

Mutat Res. 2005 Mar 7;581(1-2):97-104. Epub 2004 Dec 16.

PMID:
15725609
11.

The association of NAT1 polymorphisms and colorectal carcinoma risk: evidence from 20,000 subjects.

Cai J, Zhao Y, Zhu CL, Li J, Huang ZH.

Mol Biol Rep. 2012 Jul;39(7):7497-503. doi: 10.1007/s11033-012-1583-2. Epub 2012 Feb 11.

PMID:
22327651
13.

A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.

Katoh T, Kaneko S, Boissy R, Watson M, Ikemura K, Bell DA.

Carcinogenesis. 1998 Oct;19(10):1803-7.

PMID:
9806162
14.

Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.

Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmöller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2000 May;9(5):461-7.

15.

N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk.

Zheng W, Deitz AC, Campbell DR, Wen WQ, Cerhan JR, Sellers TA, Folsom AR, Hein DW.

Cancer Epidemiol Biomarkers Prev. 1999 Mar;8(3):233-9.

16.

A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.

Gong C, Hu X, Gao Y, Cao Y, Gao F, Mo Z.

Med Oncol. 2011 Mar;28(1):365-76. doi: 10.1007/s12032-010-9423-5. Epub 2010 Jan 23. Review.

PMID:
20099048
17.

Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.

Prawan A, Kukongviriyapan V, Tassaneeyakul W, Pairojkul C, Bhudhisawasdi V.

Eur J Cancer Prev. 2005 Jun;14(3):245-50.

PMID:
15901993
18.

N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.

Hosen MB, Islam J, Salam MA, Islam MF, Hawlader MZ, Kabir Y.

Asia Pac J Clin Oncol. 2015 Mar;11(1):78-84. doi: 10.1111/ajco.12291. Epub 2014 Nov 6.

PMID:
25376209
19.

Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.

Ying XJ, Dong P, Shen B, Wang J, Wang S, Wang G.

J Cancer Res Clin Oncol. 2011 Nov;137(11):1661-7. doi: 10.1007/s00432-011-1045-6. Epub 2011 Aug 30.

PMID:
21877196
20.

Supplemental Content

Support Center